Lilly Axes Axid: Reliant Assumes U.S. Sales And Marketing Rights
Reliant Pharmaceuticals' second adopted brand is the Lilly H2 antagonist Axid (nizatidine), a product with current annual sales of about $200 mil.
Reliant Pharmaceuticals' second adopted brand is the Lilly H2 antagonist Axid (nizatidine), a product with current annual sales of about $200 mil.